This Article Full Text Full Text (PDF) All Versions of this Article: 34/2/558    most recent 01.STR.0000051507.64423.00v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chang, C.-F. Articles by Wang, Y. Search for Related Content PubMed PubMed Citation Articles by Chang, C.-F. Articles by Wang, Y. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Stroke Transient Ischemic Attack Related Collections Gene expression Growth factors/cytokines Ischemic biology - basic studies Behavioral Changes and Stroke Transient Ischemic Attacks

(Stroke. 2003;34:558.)
© 2003 American Heart Association, Inc.

Original Contributions

Intravenous Administration of Bone Morphogenetic Protein-7 After Ischemia Improves Motor Function in Stroke Rats

Chen-Fu Chang, MD; Shinn-Zong Lin, MD, PhD; Yung-Hsiao Chiang, MD, PhD; Marisela Morales, PhD; Jenny Chou, BS; Pamela Lein, PhD; Hui-Ling Chen, MS; Barry J. Hoffer, MD, PhD Yun Wang, MD, PhD

From the National Institute on Drug Abuse, National Institutes of Health, Baltimore, Md (C-F.C., M.M., J.C., H-L.C., B.J.H., Y.W.); Tri-Service General Hospital (C-F.C., S-Z.L., Y-H.C.) and Graduate Institute of Life Sciences (H-L.C.), National Defense Medical Center, Taiwan, Republic of China; and Department of Environmental Health Sciences, Johns Hopkins University, Baltimore, Md (P.L.).

Correspondence to Yun Wang, MD, PhD, National Institute on Drug Abuse, Intramural Research Program, 5500 Nathan Shock Dr, Baltimore, MD 21224. E-mail ywang{at}intra.nida.nih.gov

Background and Purpose— We and others have previously reported that bone morphogenetic protein-7 (BMP-7), given before middle cerebral artery occlusion (MCAO), reduces ischemic injury in brain. Recent studies have indicated that receptors for BMP are upregulated after brain ischemia. It is possible that this upregulation may facilitate endogenous neurorepair in the ischemic brain. The purpose of this study was to determine the neuroregenerative effects of BMP-7 given parenterally after ischemia/reperfusion injury.

Methods— Adult Sprague-Dawley rats were anesthetized with chloral hydrate. The middle cerebral artery was transiently occluded by a filament inserted through the right internal carotid artery. The filament was removed after 60-minute ischemia to allow reperfusion. Some animals were killed 24 hours after MCAO to examine BMP-7 mRNA expression. Other animals received a single dose of intravenous BMP-7 or vehicle at 24 hours after MCAO and were used for subsequent behavioral studies and BMP-7 immunostaining.

Results— BMP-7 mRNA was upregulated 24 hours after MCAO in untreated animals. BMP-7 immunoreactivity was dose-dependently increased on the ischemic side of the hippocampus/dentate on day 6 after MCAO in animals receiving intravenous injection of BMP-7. Animals receiving BMP-7 also showed a decrease in body asymmetry from day 7 to day 14 and an increase in locomotor activity on day 14 after MCAO.

Conclusions— Our data indicate that BMP-7, given parenterally after stroke, can pass through the blood-brain barrier on the ischemic side and induce behavioral recovery in stroke animals at longer testing times.

Key Words: bone morphogenetic proteins • growth factors • nerve regeneration • stroke

This article has been cited by other articles:

				M. LLorens-Martin, I. Torres-Aleman, and J. L. Trejo Reviews: Mechanisms Mediating Brain Plasticity: IGF1 and Adult Hippocampal Neurogenesis Neuroscientist, April 1, 2009; 15(2): 134 - 148. [Abstract] [PDF]

				W.-C. Shyu, S.-Z. Lin, P.-S. Yen, C.-Y. Su, D.-C. Chen, H.-J. Wang, and H. Li Stromal Cell-Derived Factor-1{alpha} Promotes Neuroprotection, Angiogenesis, and Mobilization/Homing of Bone Marrow-Derived Cells in Stroke Rats J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 834 - 849. [Abstract] [Full Text] [PDF]

				X. Cheng, Y. Wang, Q. He, M. Qiu, S. R. Whittemore, and Q. Cao Bone Morphogenetic Protein Signaling and Olig1/2 Interact to Regulate the Differentiation and Maturation of Adult Oligodendrocyte Precursor Cells Stem Cells, December 1, 2007; 25(12): 3204 - 3214. [Abstract] [Full Text] [PDF]

				W.-C. Shyu, C.-P. Chen, S.-Z. Lin, Y.-J. Lee, and H. Li Efficient Tracking of Non-Iron-Labeled Mesenchymal Stem Cells With Serial MRI in Chronic Stroke Rats Stroke, February 1, 2007; 38(2): 367 - 374. [Abstract] [Full Text] [PDF]

				H.-L. Chen and D. M. Panchision Concise Review: Bone Morphogenetic Protein Pleiotropism in Neural Stem Cells and Their Derivatives--Alternative Pathways, Convergent Signals Stem Cells, January 1, 2007; 25(1): 63 - 68. [Abstract] [Full Text] [PDF]

				W.-C. Shyu, S.-Z. Lin, M.-F. Chiang, C.-Y. Su, and H. Li Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. J. Neurosci., March 29, 2006; 26(13): 3444 - 3453. [Abstract] [Full Text] [PDF]